Adeline Debreuve-Theresette

Adeline Debreuve-Theresette

Auto-generated profile, based on publicly available information

Adeline Debreuve-Theresette

Godinot Institute , Reims , France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2024 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
SCSarah Caillé
Sarah Caillé
ADAdeline Debreuve-Theresette
Adeline Debreuve-Theresette
GVGéraldine Vitellius
Géraldine Vitellius
SDSophie Deguelte
Sophie Deguelte
LMLuigi La Manna
Luigi La Manna
MZMohamad Zalzali
Mohamad Zalzali
Context: Medullary thyroid cancer (MTC) is a rare disease. Objective: The main objective of our study was to analyze the incidence evolution of MTC with a follow-up of more than 40 years. Further, a descriptive and survival analysis was performed according to the Kaplan–Meier analysis. Design, Setting, and Patients: This is a retrospective epidemiological study using data from the Marne-Ardennes registry from 1975 to 2018. Two hundred sixty patients with MTC were included. Main Outcome Measures: The incidence was calculated in the territory of the register (Marne and Ardennes departments of France) and standardized on the demographic structure of France. Patient and tumor characteristics were described. An analysis in a subgroup comparing hereditary and sporadic forms was performed. An analysis of survival was performed. Results: The standardized incidence shows an increasing trend over time. The incidence increased significantly from 0.41 to 0.57/100 000 person-years between 1986 and 1996 and 2008 and 2018. The MTC was hereditary in 21.2% of cases. The sex ratio (males:females) was 0.73. The average age at diagnosis was 53 years. Ninety-seven patients (37.3%) were N1, 26 (10%) were M1, and 56 (21.5%) developed metastases during the follow-up. Complete remission was obtained in 58.5% of patients. The disease was refractory for 18.1% of patients. The 5-year survival rate was 88.4%. Sporadic cases had a poorer prognosis than hereditary MTC. Conclusion: Our study demonstrates a moderate increase in the incidence of MTC between 1975 and 2018. The prognosis remains worse for sporadic MTC than for hereditary MTC.

1 December 2015 in Surgical Infections
Verified
Journal Article
Closed access
ADAdeline Debreuve-Theresette
Adeline Debreuve-Theresette
SDSaidou Diallo
Saidou Diallo
RSRenaud Siboni
Renaud Siboni
XOXavier Ohl
Xavier Ohl
EDEmile Dehoux
Emile Dehoux
OBOdile Bajolet
Odile Bajolet
Background: Surgical site infections (SSI) are a dreaded complication of total hip (THA) and knee arthroplasties (TKA), and are a major public health concern. Risk factors are well known, but no endogenous risk assessment score exists. The objective of this study to develop a score to assess endogenous risk of infection after THA or TKA. Methods: All infections after TKA and THA implanted in the department of orthopedic surgery of a teaching hospital between January 2007 and December 2012 were included. Two control groups were matched to cases on the type of prosthesis (hip or knee; first-line or revision). Results: Twenty-four SSIs after THA and 21 after TKA were registered (respective incidence during the study period: 1.56 and 1.91%). Relevant endogenous risk factors found were: Smoking (adjusted odds ratio=3.9), a BMI greater than 35 kg/mÇ (1.8), inflammatory rheumatism (7.3), and the number of operations (prosthetic or not) on the involved joint (2.9 per additional surgery). The average score of endogenous infection risk on all analyzed subjects was 3.37±3.33 (median=3, range=0-17). Mean scores were substantially different among cases and control groups: Respectively 5.84±4.04 vs 2.13±2.01 (p<0.0001). With a five-point threshold, the sensitivity and specificity of the score are respectively 62 and 91%. ASA score greater than or equal to three was not found to be substantial risk factor in this study (p=0.15). Conclusions: Endogenous infection risk score studied here was found to be relevant in discriminating cases from control groups, but requires validation in a larger cohort.

1 December 2015 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
ADA. Debreuve-Theresette
A. Debreuve-Theresette
NJN. Jovenin
N. Jovenin
ASA.C. Stona
A.C. Stona
MKM. Kraïem-Leleu
M. Kraïem-Leleu
FBF. Burde
F. Burde
JRJ.B. Rey
J.B. Rey